The Department of Medical Sciences of the RAS, Therapeutic Sciences Council meeting: Scientific projects marathon of Russian therapeutic departments "From innovative technologies and education to healthcare practice. Connective tissue diseases: diagnostic and therapeutic challenges"

Council for Therapeutic Sciences of the Russian Academy of Sciences, connective tissue dysplasia, clinical recommendations

1. Ivanova DS, Viktorova IA, Kochimov RS, et al. Diagnostics and tactics of management of patients with signs of connective tissue dysplasia, headache and disorder of sensitivity. Literature review. Therapy. 2020;(6):124-30. (In Russ.) doi:10.18565/therapy.2020.6.124-130.

2. Viktorova IA, Ivanova DS, Poltavtseva AM, et al. Modern criteria of diagnosis of the main dysplasia phenotypes (Marfan and Chernogubov-Ehlers-Danlos syndromes): sufficiency and applicability to medical practice. Russian Medical Inquiry. 2023;7(3):144-9. (In Russ.) doi:10.32364/2587-6821-2023-7-3-144-149.

3. Viktorova IA, Ivanova DS, Kochimov RSh, et al. Methods for the diagnosis and management of patients with hypermobile Ehlers-Danlos syndrome. Russian Medical Inquiry. 2020;4(8):498-503. (In Russ.) doi:10.32364/2587-6821-2020-4-8-498-503.

4. Viktorova IA, Ivanova DS, Konshu NV, et al. Role of joints hypermobility in diagnostics of syndromic forms of conjunctive tissue dysplasia and rheumatic disorders. Therapy. 2018;(6):59-64. (In Russ.) doi:10.18565/therapy.2018.6.59-64.

5. Viktorova IA, Konshu NV, Kiseleva DS. Osteogenesis imperfecta: polymorphism of clinical manifestations and management. The Russian Archives of Internal Medicine. 2015;2(22):69-73. (In Russ.) doi:10.20514/2226-6704-2015-0-2-69-73.

6. Viktorova IA, Kiseleva DS, Konshu NV. Diagnostics of joint hypermobility in outpatient practice. Rossiyskiye meditsinskiye vesti. 2011;16(1):62-9. (In Russ.)

7. Viktorova IA, Konshu NV, Bagisheva NV. Stratification of osteoarthrosis progression at patients with syndrome of hypermobility joints on the basis of level determination of biochemical marker С-terminal telopeptide formed after II type-collagen degradation Spravochnik vracha obshchey praktiki. 2015;2:52-8. (In Russ.)

8. Viktorova IA, Konshu NV, Kiseleva DS. Osteoarthrosis in patients with joint hypermobility: severity and risk simulation. Vraсh. 2014;5:72-6. (In Russ.)

9. Viktorova IA, Konshu NV, Ivanova DS, et al. Joint hypermobility in association with osteoarthritis: a familial case. Profilakticheskaya Meditsina. 2017;20(1):42-5. (In Russ.) doi:10.17116/profmed201720142-45.

10. Viktorova IA, Konshu NV. Osteoarthrosis at patients with family hypermobility of joints: stratification of the risk of occurrence and the type of progression. Medical News of the North Caucasus. 2014;9(4):310-4. (In Russ.) doi:10.14300/mnnc.2014.09087.

11. Viktorova IA, Ivanova DS, Konshu NV. Prospective two-year observation of patients with the syndrome of joint hypermobility. Therapy. 2019;(7):84-90. (In Russ.) doi:10.18565/therapy.2019.7.84-90.

12. Viktorova IA, Ivanova DS, Nechaeva GI, et al. Rehabilitation of patients with connective tissue dysplasia in outpatient practice. Therapy. 2020;6(40):8-17. (In Russ.) doi:10.18565/therapy.2020.6.8-17.

13. Viktorova IA, Kiseleva DS, Kulniyazova GM. Joint hypermobility syndrome: diagnosis and treatment of patients in outpatient practice. Lechashchiy vrach. 2014;4:42-7. (In Russ.)

14. Viktorova IA, Ivanova DS, Moiseeva MV, et al. Course patterns and patient management with joint hypermobility syndrome in the post-COVID-19 period. Russian Medical Inquiry. 2022;6(3):133-9. (In Russ.) doi:10.32364/2587-6821-2022-6-3-133-139.

15. Viktorova IA, Nechayeva GI, Konev VP, et al. Clinical and prognostic criteria of connective tissue dysplasia. Rossiyskiye meditsinskiye vesti. 2009;14(1):76-85. (In Russ.)

16. Akatova EV, Arutyunov GP, Baranov AA, et al. Clinical recommendations. Undifferentiated connective tissue dysplasia. Therapy. 2024;10(5S):1-43 (In Russ.) doi:10.18565/therapy.2024.5suppl.1-43.

17. Nechaeva GI, Martynov AI. A modern approach to connective tissue dysplasia in cardiology: diagnosis and treatment: a guide for doctors. Moscow: GEOTAR-Media, 2023. 432 с. (In Russ.) ISBN: 978-5-9704-7325-2.

18. Shilova MA, Druk IV, Globa IV. Changes in the vascular bed of the brain in sudden death of young people. Forensic medical examination. 2018;61(1):55-9. (In Russ.)

19. Pigolkin YuI, Shylova MA, Zakharov SN, et al. The sudden death among the young persons under effect of the different forms of physical loads. Forensic Medical Expertise. 2019;62(1):50-5. (In Russ.)

20. Druk IV, Nechaeva GI, Lyalyukova EA, Drokina OV. Cardiovascular syndromes of connective tissue dysplasia in young people: frequency of registration, factors of formation. Lechaschi Vrach. 2014;(6):72-8. (In Russ.)

21. Druk IV, Nechaeva GI. Valve the syndrome of connective tissue dysplasia: characteristic clinical manifestations, the prognosis of the course. International Journal of Heart and Vascular Diseases. 2015;3(8):32-9. (In Russ.)

22. Smyalovsky VE, Drug IV, Smyalovsky DV. Features of the course of intracranial arterial aneurysms and arteriovenous malformations in patients with connective tissue dysplasia Journal of Neurology and Psychiatry named after S. S. Korsakov. 2014;114(8):304. (In Russ.)

23. Druk IV, Rozhdestvenskiĭ AS, Smyalovsky DV, et al. Cerebral vascular syndrome of connective tissue dysplasia as a cause of subarachnoid hemorrhage in young patients. S. S. Korsakov Journal of Neurology and Psychiatry. 2018;118(12-2):15-22. (In Russ.) doi:10.17116/jnevro201811812215.

24. Nechaeva G, Druk I, Potapov V. Arrhythmias among patients with multiple connective tissue abnormalities. European Heart Journal Supplements. 2014;1472.

25. Druk I, Nechaeva G, Smjalovskij V, et al. The prevalence of non-fatal adverse cardiovascular events among young patients with multiple abnormalities of connective tissue:7-year follow-up. European Heart Journal. 2013;34:5170. doi:10.1093/eurheartj/eht310.P5170.

26. Druk IV, Nechaeva GI, Aseeva OV, et al. Personalized assessment of the risk of adverse cardiovascular complications in young patients with connective tissue dysplasia. Kardiologiia. 2015;55(3):75-84. (In Russ.)

27. Potapov VV, Druk IV, Nechaeva GI, et al. Exercise tolerance and speckle tracking characteristics of right ventricular myocardial deformity in young patients with connective tissue dysplasia, circulatory pathology and cardiac surgery. 2014;1:42-6. (In Russ.)

28. Loginova EN, Nechaeva GI, Dakuko AN, et al. Left ventricular longitudinal strain in patients with undifferentiated connective tissue disease and arrhythmia. Russian Journal of Cardiology. 2023;28(12):5665. (In Russ.) doi:10.15829/1560-40712023-5665.

29. Loginova EN, Nechaeva GI, Dakuko AN, et al. Assessment of N-terminal pro-brain natriuretic peptide in patients with arrhythmia due to undifferentiated connective tissue disease. Russian Journal of Cardiology. 2023;28(11):5641. (In Russ.) doi:10.15829/1560-4071-2023-5641.

30. Druk IV, Nechaeva GI. Methodology of providing therapeutic and preventive care to young patients with cardiovascular syndromes of connective tissue dysplasia: a short-term assessment of effectiveness. Medical science and education of the Urals. 2015;16(2-1):13-7. (In Russ.)

31. Lindsey ML, Jung M, Hall ME, DeLeon-Pennell KY. Proteomic analysis of the cardiac extracellular matrix: clinical research applications. Expert Rev Proteomics. 2018;15(2):105-12. doi:10.1080/14789450.2018.1421947.

32. Cui H, Chen Y, Li K, et al. Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection. Eur Heart J. 2021;42(42):4373-85. doi:10.1093/eurheartj/ehab605.

33. Li XJ, Pan HT, Chen JJ, et al. Proteomics of Uterosacral Ligament Connective Tissue from Women with and without Pelvic Organ Prolapse. Proteomics Clin Appl. 2019;13(4):e1800086. doi:10.1002/prca.201800086.

34. Shen YH, LeMaire SA. Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections. Curr Probl Surg. 2017;54(3):95-155. doi:10.1067/j.cpsurg.2017.01.001.

35. Bhandari R, Aatre RD, Kanthi Y. Diagnostic approach and management of genetic aortopathies. Vasc Med. 2020;25(1):63-77. doi:10.1177/1358863X19886361.